Home, home below the range: all five deals this week priced below the range. There were eleven companies on the IPO calendar this week, but only five were ...read more
Mirna Therapeutics, which is developing microRNA replacement therapies for liver cancer, raised $44 million by offering 6.3 million shares at $7. Mirna Therapeutics plans to list on the Nasdaq under the symbol MIRN. Mirna Therapeutics initially filed...read more
Mirna Therapeutics, which is developing microRNA replacement therapies for liver cancer, lowered the proposed deal size for its upcoming IPO on Wednesday. The Austin, TX-based company now plans to raise $44 million by offering 6 million shares at a price of $7....read more
The last week of September has 11 IPOs on the calendar – more IPOs than all of August 2015. Out of 134 offerings so far in 2015, 61 have been health care...read more
US IPO Weekly Recap: Only five deals get done after massive valuation cuts
Home, home below the range: all five deals this week priced below the range. There were eleven companies on the IPO calendar this week, but only five were ...read more
Mirna Therapeutics prices IPO at $7, half the original midpoint
Mirna Therapeutics, which is developing microRNA replacement therapies for liver cancer, raised $44 million by offering 6.3 million shares at $7. Mirna Therapeutics plans to list on the Nasdaq under the symbol MIRN. Mirna Therapeutics initially filed...read more
Mirna Therapeutics decreases proposed IPO deal size
Mirna Therapeutics, which is developing microRNA replacement therapies for liver cancer, lowered the proposed deal size for its upcoming IPO on Wednesday. The Austin, TX-based company now plans to raise $44 million by offering 6 million shares at a price of $7....read more
Week ahead: 11 IPOs set to price during the week of September 28
The last week of September has 11 IPOs on the calendar – more IPOs than all of August 2015. Out of 134 offerings so far in 2015, 61 have been health care...read more